InnovAge
INNV
$7.52
Share price
11.74%
Change (1 day)
46.59%
Change (1 year)
Categories
Revenue for InnovAge (INNV)
Revenue in 2022 (TTM): $0.68 B
According to InnovAge's latest financial reports the company's current revenue (TTM) is $0.68 B. In 2021 the company made a revenue of $0.67 B an increase over the years 2020 revenue that were of $0.60 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for InnovAge from 2020 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $0.68 B | 1.86% |
| 2021 | $0.67 B | 11.4% |
| 2020 | $0.60 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Merck MRK | $57.86 B | 8,300.29% | 🇺🇸 USA |
 Cocrystal Pharma
COCP | N/A | N/A | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $1.77 M | -99.74% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $3.57 B | 419.07% | 🇮🇪 Ireland |